Quantcast
Last updated on April 17, 2014 at 17:30 EDT

Latest Elekta AB Stories

2014-04-05 04:21:30

First-generation system for testing at University Medical Center Utrecht is next step in what may be a quantum leap in tumor visualization during radiotherapy UTRECHT, Netherlands, April 5, 2014 /PRNewswire/ -- Elekta (NSE:EKTAb), Royal Philips (NYSE:PHG, AEX:PHIA) and University Medical Center (UMC) Utrecht (the Netherlands) announced today that the initial components of the world's first high-field magnetic resonance imaging (MRI) guided radiation therapy system are being installed...

2014-04-02 08:34:07

In complex cases, Medical University Innsbruck clinicians exploit speed and accuracy advantages of new groundbreaking linear accelerator INNSBRUCK, Austria, April 2, 2014 /PRNewswire/ -- Medical University Innsbruck is the first center in Austria to begin treating patients with Elekta's Versa HD(TM), a radiation therapy system equipped with advanced beam-shaping and high dose rate technologies to deliver extremely precise treatments in shorter treatment times. Since January 14, the...

2014-04-01 08:30:13

VIENNA, April 1, 2014 /PRNewswire/ -- ESTRO Booth #6200 - At ESTRO33, Elekta will demonstrate a comprehensive array of advanced solutions for cancer management. These products include the Versa HD(TM) treatment system, Monaco® 5 treatment planning system and Esteya® electronic brachytherapy system for treating skin cancer. ESTRO33 convenes April 4-8 at the Reed Messe Vienna Congress Centre. Follow @Elekta for live tweets from the show floor. Elekta's theme for this year's ESTRO,...

2014-03-13 12:28:27

CRAWLEY, England, March 13, 2014 /PRNewswire/ -- A little over a year after Elekta launched its Versa HD(TM) radiation therapy system, this groundbreaking linear accelerator is routinely being used in the delivery of stereotactic body radiotherapy (SBRT) and radiosurgery (SRS) programs worldwide, often using volumetric modulated arc therapy (VMAT). The company reports that many Versa HD systems operating clinically are actively engaged in SBRT and/or SRS programs. Elekta designed...

2013-12-26 08:23:23

Evangelische Kliniken Gelsenkirchen anticipates performance improvements across a wide range of cancers throughout the body GELSENKIRCHEN, Germany, Dec. 26, 2013 /PRNewswire/ -- On October 28, clinicians at Evangelische Kliniken Gelsenkirchen (Gelsenkirchen, Germany) launched a new era of radiation therapy speed and accuracy with their first Versa HD(TM) case, a 72-year-old female patient with advanced (metastatic) cancer. Because the patient had received her first few fractions on...

2013-12-18 12:25:34

Agreement secures full Elekta solution across the McLaren enterprise ATLANTA, Dec. 18, 2013 /PRNewswire/ -- The ability to effectively manage data across disparate health systems to help drive quality care will be a cornerstone for health systems of the future. Elekta is proud to announce today that it has joined forces with Michigan-based McLaren Health Care to launch MOSAIQ® oncology information system throughout McLaren's cancer network. This partnership will enable McLaren to...

2013-12-13 08:25:26

NEW YORK, Dec. 13, 2013 /PRNewswire/ -- The first Esteya® electronic brachytherapy system in the United States has been installed at New York's Memorial Sloan-Kettering Cancer Center. Esteya by Nucletron, an Elekta company, is a new approach for skin cancer treatment that relies on a small, high dose rate (HDR) X-ray source to apply high precision radiotherapy directly to the cancer site. "With support from Elekta, Memorial Sloan-Kettering will lead a multicenter clinical study...

2013-11-05 08:35:54

Hospital La Fe's study demonstrates user- and patient-friendliness and short procedure time with Esteya VALENCIA, Spain, Nov. 5, 2013 /PRNewswire/ -- Hospital La Fe, a long-time clinical collaborator of Nucletron, an Elekta company, is nearing the conclusion of the enrollment phase of a clinical study with the new Esteya® electronic brachytherapy system for treating skin cancer. First clinical data on efficacy are expected in about two months, but physicians in the center's...

2013-10-25 08:24:48

STOCKHOLM, Oct. 25, 2013 /PRNewswire/ -- Elekta announced today that Niklas Savander has been appointed as its next President and Chief Executive Officer, effective May 1, 2014. Niklas Savander will succeed Tomas Puusepp, who will continue with Elekta as a working member of its Board of Directors per the same date. (Photo: http://photos.prnewswire.com/prnh/20131025/CL04205) Niklas Savander has extensive experience from senior management positions both within Hewlett Packard and...

2013-10-02 08:30:21

ATLANTA, Oct. 2, 2013 /PRNewswire/ -- Esteya®, an electronic brachytherapy system, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA), enabling medical centers in the United States to offer their patients with skin cancer a new treatment option. Esteya is a new approach for high precision skin cancer treatment. The system relies on a small, high dose rate (HDR) to apply radiation directly to the cancerous site. This direct delivery enables Esteya to focus...